We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INHD:NASDAQInno Holdings Inc. Analysis

Data as of 2026-05-19 - not real-time

$1.40

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Inno Holdings Inc. is trading well below its historical highs and sits near the lower end of its 30‑day support band, with technical indicators showing deep oversold conditions and a bearish price trend. The RSI is firmly in oversold territory, the MACD histogram has turned positive but the overall MACD line remains below the signal, and the 20‑day SMA sits far beneath both the 50‑day and 200‑day averages, underscoring weak momentum. Volume has been decreasing, and the beta is negative, indicating that the stock moves opposite to the market and contributes to heightened price instability. Recent material news reveals a 1‑for‑20 reverse stock split aimed at meeting Nasdaq’s minimum bid price requirement, which triggered a sharp after‑hours sell‑off and adds regulatory uncertainty. Additionally, the company announced an AI strategic plan, suggesting a pivot toward higher‑tech services, yet this initiative is nascent and unproven.
Fundamentally, the company reports negligible revenue relative to its market cap, negative profit margins, and zero EBITDA, with operating and free cash flow deeply negative. The balance sheet shows modest cash and minimal debt, but the book‑value per share is far above the current market price, yielding an extremely low price‑to‑book multiple. No dividend is paid, and earnings guidance is absent, leaving investors with limited upside catalysts beyond the speculative AI effort. The combination of distressed fundamentals, volatile technicals, and compliance‑driven corporate actions signals a high‑risk environment that warrants caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Reverse split-induced volatility
  • Bearish technical indicators
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from AI strategic plan
  • Extremely low price‑to‑book valuation
  • Continued earnings deficits

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Uncertain turnaround prospects
  • High beta and volatility
  • Lack of sustainable dividend or earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth94.90%
Profit Margin-86.84%
ROE-14.70%
ROA-8.75%
Debt/Equity0.38
P/B Ratio0.3
Op. Cash Flow$-9554644
Free Cash Flow$-7192444

Technical Analysis

TrendBearish
RSI23.1
Support$1.28
Resistance$3.90
MA 20$2.01
MA 50$9.93
MA 200$437.29
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-1.21
Volatility270.03%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.